Hologic and Agfa have finalized an agreement under which Hologic will manufacture a digital mammography system to be private-labeled and distributed by Agfa in certain international markets. The system, which Agfa will call Embrace, will be built around
Hologic and Agfa have finalized an agreement under which Hologic will manufacture a digital mammography system to be private-labeled and distributed by Agfa in certain international markets. The system, which Agfa will call Embrace, will be built around Hologic's flat-panel amorphous selenium technology but will include Agfa image processing and information technology. The Joint Development and OEM Purchase Agreement is an outgrowth of a Letter of Intent signed by the two companies in April 2002.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.